A Novel Itraconazole Pulse Therapy Schedule in the Treatment of Tinea Capitis in Children

Figures & data

Table 1 Characteristics of Patients with Tinea Capitis

Patient No.	Age (Years)	Sex	Weight (kg)	Dose of Itraconazole (mg/d)	No. of Pulse	Organism	Adverse Reaction	Follow Up
1	2	M^a	12	120	2	M. canis	None	No relapse
2	3	F^b	13.5	100	2	N. gypsea	None	No relapse
3	5	M	18.5	150	3	M. canis	None	No relapse
4	8	M	23	200	3	M. canis	None	No relapse

Abbreviations: ^aF, female; ^bM, male.

Figure 1 (A) Clinical manifestation of patient 1. (B) Complete remission after treatment of patient 1.

Figure 2 (A) Clinical manifestation of patient 2. (B) Complete remission after treatment of patient 2.

Figure 3 (A) Clinical manifestation of patient 3. (B) Complete remission after treatment of patient 3.

Figure 4 (A) Clinical manifestation of patient 4. (B) Complete remission after treatment of patient 4.